The global autotransfusion devices market was estimated USDXX million in 2014 and is expected to reach USDXX million by 2023, registering a compound annual growth rate of XX%. The manufacturers across the globe are coming up with new technologies in order to improvise and to meet the challenges endured by the medical facilities. Auotransfusion is a process in which a person receives its own blood for transfusion in place of separate donor’s blood. The system has reduced the chances of blood infections, has enhanced the transfer of oxygen and has reduced the chances of isosensitization. The increase in cardiovascular disease and heart diseases are the prime factors for the growth of the market. Also, the method has been adopted by various hospitals in order to improve their patient outcome.
Product Outlook and Trend Analysis:
On the basis of product type the global autotransfusion devices market is categorized into on pump transfusion devices and off pump transfusion devices. Among them the on pump transfusion segment has acquired the largest share of the market and will continue to grow at a compound annual growth rate of XX%. On the other hand the off pump transfusion device will witness significant grow in the near future.
End Users Outlook and Trend Analysis:
Based on the end users the global autotransfusion devices market is divided into Ambulatory Surgical Centers, Hospitals, and Cardiac Research Centers. The ambulatory surgical centers have acquired the largest share in the market and will continue to grow at a compound annual growth rate of XX% over the forecast period. The factors which have leaded the rise in demand of this segment are availability of advancement equipments, professional surgeons and availability of recovery rooms. The hospitals segment and will considerably grow at a compound annual growth rate of XX% over the forecast period.
Regional Outlook and Trend Analysis:
North-American region has acquired the largest market share among the others and will continue to grow at a compound annual growth rate of XX%. U.S. and Canada has witnessed large number of cardiovascular diseases due to stressful lifestyle, and changing food habits which has leaded the growth of this segment. On the other hand regions such as Asia-Pacific and Europe will acquire fast growth in the autotranfusion devices market in the near future.
The leading manufacturer of the autotransfusion devices are Advancis Surgical, Haemonetics, Terumo, Fresenius Kabi, LivaNova, Global Blood Resources, Stryker, Redax, Atrium Medical and Medtronic. Various companies have invested in the research and development department for the development and advancement of new technologies. Due to new participants entering into the market, the market size will certainly expand in the near future.
The Autotransfusion Devices Market is divided based on:
on pump transfusion
off pump transfusion devices
By End Users:
Ambulatory Surgical Centers
Cardiac Research Centers
Rest of Europe
Rest of Asia Pacific
Rest of South America
Middle East and Africa
Rest of MEA